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journal homepage: www.urol-sci .comEditorialKetamine uropathy“‘There Is Nothing New Under the Sun’. In the 21st century, with
the development of modern medicine, some may believe that we
already knowmost of the knowledge about the human body. How-
ever, ketamine cystitis is a new disease, and its pathomechanism is
far from well-understood. This disease causes pain and affects the
quality of life of many young people. If we can determine a way
to cure the disease, I believe it would bring honor and satisfaction
to the researcher or clinician!”
The above letter was the email I wrote in 2011 to Professor Lane,
the director of the Graduate Institute of Clinical Medical Science,
China Medical University, Taiwan, in which I told him the story of
ketamine uropathy (KU). Ketamine abuse is a serious problem in
Taiwanese society. Many young people who abuse ketamine suffer
from severe lower urinary tract symptoms such as urgency, fre-
quency, nocturia, and hematuria. Some even need to wear diapers
in the long-term for urinary urgency incontinence. I hope that in
conjunctionwith various related ﬁelds of researchers, we can deter-
mine the key treatment for KU.
Thus far, in the past 4 years, the pathophysiological mechanism
of KU is still not fully understood, but there are a growing number
of studies in both the basic and clinical ﬁelds. The disease is preva-
lent in some Asian countries and areas, such as Taiwan, Hong Kong,
Singapore, and Malaysia, and there have been additional cases re-
ported in European countries and the United States in recent
years.1,2 It is possible that the disease will become prevalent not
only in Eastern countries, but also in Western countries.
In this issue of Urological Science, we publish a number of clinical
and basic research articles on KU. In the future, we hope that
through a national registry and national cooperation for caring
for patients with KU, we will come to know more about the preva-
lence and the impact of this disease on patients' life quality, and
eventually, wewill ﬁnd effectivemethods to treat patients suffering
from KU.
1. Ketamine cystitis: its urological impact and management
In the past decade, ketamine was available illegally as a recrea-
tional drug in Asian countries and Taiwan. Ketamine abuse is
increasing. Tsai and Kuo3 from Hualien, Taiwan, reviewed the inci-
dence of lower urinary tract symptoms in ketamine abuse patients,
their possible pathophysiology and clinical presentation, and the
present available management for ketamine cystitis.
2. Imaging diagnosis of KU
Although the lower urinary tract is the primary site affected inKU,
involvement of the upper urinary tract is common. Shen and Wang4http://dx.doi.org/10.1016/j.urols.2015.09.002
1879-5226/Copyright © 2015, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).fromTaipei, Taiwan, evaluated the extent and complications of KU af-
ter excluding other causes of uropathy. A comprehensive strategy for
KU evaluation through imaging is essential for effectively managing
complications and preventing further renal function deterioration.
3. The burden of KC in Chinese society
KCprimarily affects young tomiddle-aged ketamineabusers, and
has become a global phenomenon. Ma and Chu5 from Hong Kong
reviewed the scope and burden of KC in the Chinese population in
Asia, stating the current status of the management pathway, and
reviewing the current understanding of the pathophysiology of KC.
4. Intravesical hyaluronic acid treatment for KC: preliminary
results
The clinical features of KC are very similar to those of bladder
pain syndrome/interstitial cystitis. Intravesical administration of
hyaluronic acid (HA) is one of the regimens for treating bladder
pain syndrome/interstitial cystitis. Meng et al6 investigated
whether intravesical HA therapy may improve lower urinary tract
symptoms of patients with KC. The authors concluded that intra-
vesical HA therapy may have short-term beneﬁts for improving
bladder pain and voiding symptoms in patients with KC.
5. The protective effect of green tea catechins on KC in a rat
model
Green tea is a popular health drink worldwide. Previous studies
have identiﬁed the strong anti-inﬂammatory/antioxidant proper-
ties of green tea. Juan7 from Kaohsiung, Taiwan, investigated
whether there was a protective effect of green tea epigallocatechin
gallate (EGCG) on long-term ketamine ulcerative cystitis, for which
a ketamine addiction rat model was used. The authors' results show
that simultaneous EGCG and ketamine reversed ketamine damage
to almost control level, showing the protective effects of EGCG. This
protective effect may come from its anti-inﬂammatory and antiﬁ-
brotic properties.
6. Assessment of ketamine uropathy
Ketamine uropathy (KU) is a relatively new clinical entity. There
is currently no consensus about the assessment and evaluation for
KU. Yang8 from Taipei, Taiwan report the consensus of the Assess-
ment of Ketamine Uropathy. A group of experts in lower urinary
tract dysfunction and cystitis met together several times to discuss
optimal assessment for KU. The draft was presented at theiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Editorial / Urological Science 26 (2015) 149e150150consensus meeting held in Taichung, Taiwan on April 12, 2015. The
authors conclude that by using standardized tools to assess patients
with ketamine abuse, patients' characteristics can be clariﬁed and
different therapeutic strategies for ketamine uropathy can be
compared in the future.
7. Long-term efﬁcacy of fulguration of trigonitis for recurrent
urinary tract infections in women
Womenwith a longstanding history of recurrent urinary tract in-
fections represent a challenging population because of the gradual
development of antibiotic resistance and frequent antibiotic al-
lergies. Hussain and Zimmern9 report on the long-term results of
women with recurrent urinary tract infections and trigonitis who
were treated with endoscopic fulguration. Cystoscopy with fulgura-
tion of trigonitis was performed under anesthesia with a 1-year
minimum follow-up. Trigonitis was deﬁned as a condition of inﬂam-
mation of the trigone region of the bladder. Their results showed
that resolution of trigonitis at 6 months was noted in 25 (76%) pa-
tients. The authors concluded that the patients with resolved trigo-
nitis at 6 months after cystoscopy with fulguration of trigonitis did
their best; however, both groups beneﬁted from the procedure
over time.
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